Gradient Versus Isocratic Elution in Reversed-Phase HPLC Purity Chromatograms: What One Peptide Isolation Study Reported

Purity chromatograms generated by reversed-phase high-performance liquid chromatography (RP-HPLC) are the routine basis on which peptide and small-protein preparations are characterised, and the published literature includes detailed laboratory accounts of how elution mode and mobile-phase composition shape those chromatograms. One such account described the isolation of recombinant human insulin-like growth factor 1 (rhIGF-1) and reported that isolation was complicated by several rhIGF-1 variants that co-purified on conventional chromatographic media [1]. In that laboratory work the co-eluting species were characterised as consisting primarily of a methionine-sulfoxide variant of the correctly folded molecule, a misfolded form, and the methionine-sulfoxide variant of that misfolded form [1]. The analytical starting point reported in that study was an RP-HPLC procedure using a 5-micron C18 column, an acetonitrile–trifluoroacetic acid (TFA) isocratic elution, and elevated temperature, a combination that the authors reported gave baseline resolution of all four species [1]. This analytical method was then described as a development tool for establishing a process-scale chromatography step, in which the 5-micron analytical packing material was replaced with a larger particle size in order to reduce back-pressure and cost [1]. Because the TFA counter-ion was reported to bind tightly to proteins and to be difficult to dissociate afterwards, a combination of acetic acid and sodium chloride was substituted in the reported process conditions [1]. On the question of elution mode, the study reported that isocratic separations were not good process options owing to problems with reproducibility and control [1]. A shallow gradient elution using premixed mobile-phase buffers at the same linear velocity was reported to give an equivalent separation at low load levels while minimising solvent degassing, but at higher loading a loss of resolution was observed [1]. This reported load dependence is the central chromatographic observation of the paper: in that laboratory system, a gradient chromatogram that appeared equivalent to the isocratic reference at analytical load did not retain the same resolution when loading was increased [1]. The authors then reported evaluating a matrix of buffers for their effects on the separation [1]. Elevated pH was reported to produce a significant shift in both the elution order and the relative retention times of the principal rhIGF-1 variants, which the authors associated with a substantial increase in effective capacity [1]. An increase in ionic strength was reported to improve resolution further [1]. Several different chromatographic media were also evaluated with respect to particle size, shape, and pore diameter under the improved mobile-phase conditions [1]. The reported outcome was that the conditions were scaled up 1305-fold and yielded superimposable chromatograms, 96% recovery, and greater than 99% purity, which the authors attributed to optimisation of pH, ionic strength, and temperature [1]. For researchers reading purity chromatograms, the methodological points carried by this single report are narrow and should be read as such. The findings come from one laboratory analytical and preparative chromatography study of one recombinant protein and its fermentation-derived variants; they are in vitro separation-science observations and were not measurements in animals or in people [1]. The paper documents that elution order and relative retention time in that system were not fixed properties of the analytes but shifted with mobile-phase pH [1], that a resolution figure established at analytical load did not necessarily hold at higher load under gradient conditions [1], and that a reported purity value of greater than 99% was the endpoint of a defined combination of column chemistry, particle characteristics, counter-ion, pH, ionic strength, and temperature rather than of the gradient programme alone [1]. Whether comparable behaviour occurs for other peptides, other stationary phases, or other variant profiles was not addressed by this study.